This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ungvari, Z. I. Search for Related Content PubMed PubMed Citation Articles by Ungvari, Z. I. Related Collections Growth factors/cytokines

(Circulation. 2007;116:1221-1223.)
© 2007 American Heart Association, Inc.

Editorial

Endothelium-Derived Bone Morphogenic Protein Antagonists May Counteract the Proatherogenic Vascular Effects of Bone Morphogenic Protein 4

Zoltan I. Ungvari, MD, PhD

From the Department of Physiology, New York Medical College, Valhalla.

Correspondence to Zoltan Ungvari, MD, PhD, Department of Physiology, New York Medical College, Valhalla, NY 10595. E-mail zoltan_ungvari@nymc.edu

Key Words: Editorials • atherosclerosis • endothelium • inflammation • shear stress

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
In the present issue of Circulation, Chang et al¹ report novel shear stress–sensitive paracrine mechanisms that regulate the activity of bone morphogenetic proteins (BMPs) in the vascular wall. BMP2 and BMP4 are structurally related members of the transforming growth factor-ß superfamily. Recent studies demonstrated that vascular endothelial and smooth muscle cells are a significant source of BMPs,^2–8 which regulate a host of cellular functions, including cardiovascular development,⁹ neovascularization in tumors,¹⁰ and smooth muscle cell chemotaxis in response to vascular injury,¹¹ and control the balance between proliferation and activation of apoptosis in pulmonary arterial endothelial and smooth muscle cells.¹²

Article p 1258

Many lines of evidence suggest that BMPs may function as proinflammatory, prohypertensive, and proatherogenic mediators in the vessel wall.¹³ Recent studies have demonstrated a striking upregulation of BMP2/4 in atheroprone vascular regions and atherosclerotic lesions,^5,6,11,14,15 and hypotheses have been put forward that endothelium-derived BMPs contribute to vascular calcification (reviewed elsewhere^16,17). In vitro, BMP2 and BMP4 were shown to exert proinflammatory effects. Activation of BMP signaling by either overexpression of BMP2/4 in vascular cells or administration of recombinant BMPs activates NAD(P)H oxidases, which results in cellular oxidative stress and endothelial dysfunction (Figure, A and B).¹³ Chronic BMP4 infusion in C57Bl/6 and apolipoprotein-null mice also impairs endothelium-dependent vasodilation and induces arterial hypertension in an NAD(P)H oxidase–dependent manner.⁸ BMP2 and BMP4 also elicit endothelial activation, thus enhancing monocyte adhesiveness.^1,3–6 Evidence indicates that in endothelial cells BMP2 and BMP4 activate mitogen-activated protein kinase pathways and nuclear factor-B,^3,6 at . . . [Full Text of this Article]

This article has been cited by other articles:

				A. Csiszar, N. Labinskyy, H. Jo, P. Ballabh, and Z. Ungvari Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H569 - H577. [Abstract] [Full Text] [PDF]